XABLECATH
XableCath is a medical device innovator, providing design leadership, industry expertise and resources to bring concepts to market as new products. Strong emphasis is placed on projects providing cost-effective treatment options for peripheral and cardiovascular disease states.
XABLECATH
Industry:
Health Care Manufacturing Medical Device
Founded:
2013-01-01
Address:
Salt Lake City, Utah, United States
Country:
United States
Website Url:
http://www.xablecath.com
Total Employee:
11+
Status:
Closed
Contact:
44 75 8713 2425
Email Addresses:
[email protected]
Total Funding:
1.17 M USD
Technology used in webpage:
IPhone / Mobile Compatible Google Font API Euro Amazon CloudFront OpenResty Google Adsense AWS Global Accelerator AdBlock Acceptable Ads Google Adsense For Domains
Current Employees Featured
Founder
Investors List
Healthbox
Healthbox investment in Seed Round - XableCath
Official Site Inspections
http://www.xablecath.com
- Host name: 185.107.56.197
- IP address: 185.107.56.197
- Location: Netherlands
- Latitude: 52.3824
- Longitude: 4.8995
- Timezone: Europe/Amsterdam
More informations about "XableCath"
XableCath Company Profile 2024: Valuation, Funding & Investors
XableCath General Information Description. Developer of catheter-based devices created to treat peripheral and cardiovascular diseases in patients. The company's devices combine guidewire …See details»
XableCath - Overview, News & Similar companies | ZoomInfo.com
XableCath, Inc., was founded in 2014 to commercialize catheters for the treatment of vascular disease. Its revolutionary technology allows effectiv e peripheral intravascular treatment, …See details»
Xablecath Inc Company Profile | Salt Lake City, UT | Competitors ...
Find company research, competitor information, contact details & financial data for Xablecath Inc of Salt Lake City, UT. Get the latest business insights from Dun & Bradstreet.See details»
XableCath - Company Profile - Tracxn
XableCath - Over-the-wire catheter designed for facilitating guide wire and catheter access in peripheral and coronary lesions. Raised a total funding of $1.17M over 2 rounds from 2 …See details»
XableCath - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of ... obfuscated. obfuscated — Oct 16, 2014: Seed Round - XableCath . 1: …See details»
XableCath - Contacts, Employees, Board Members, Advisors
Organization. XableCath . Connect to CRM . Save . Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 2.See details»
XableCath Crossing Catheters FDA Cleared - Cardiac Vascular News
SALT LAKE CITY, Jan. 30, 2019 (GLOBE NEWSWIRE) -- XableCath, Inc., announced that its XableCath™ blunt and abrasion tip catheters, were cleared by the FDA as Peripheral Crossing …See details»
XableCath Receives FDA Clearance for Broadly Effective Catheter …
Dec 18, 2017 XableCath President and CEO, Lisa Dunlea commented, “Different from most interventional devices used to facilitate lesion passage, XableCath was designed to be one of …See details»
XableCath™ Receives CE Mark - Cardiac Vascular News
Feb 6, 2020 XableCath™ Receives CE Mark. Shared by Ken Dropiewski on February 6, 2020. More in Peripheral/Endo: Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® …See details»
XableCath wins CE Mark approval for crossing catheters
Mar 2, 2020 XableCath recently announced its Crossing Catheters received CE Mark approval for peripheral use. The crossing devices come in blunt tip and abrasion tip versions with a variety of diameters and lengths. The company …See details»
XableCath crossing catheters have received CE mark for peripheral …
Feb 10, 2020 XableCath received US Food and Drug Administration (FDA) clearance for its crossing devices last year. Physicians in the USA have had remarkable success using the …See details»
Xablecath Inc Company Profile | Salt Lake City, UT | Competitors ...
Home / business directory / finance and insurance / securities, commodity contracts, and other financial investments and related activities / other financial investment activities / united states …See details»
PAD catheter effective in all lesion types receives FDA clearance
Jan 10, 2018 Procedures using the XableCath blunt tip catheters can be performed quickly and safely, allowing physicians to more effectively treat peripheral arterial disease (PAD). “The …See details»
XableCath Crossing Catheters cleared by FDA - Vascular News
Feb 1, 2019 XableCath, Inc. has announced that its blunt and abrasion tip catheters have been cleared by the US Food and Drug Administration (FDA) as peripheral crossing catheters. The …See details»
FDA Clears XableCath Crossing Catheters - Endovascular Today
Jan 30, 2019 XableCath is commencing a selective commercial launch in Q1 2019. The catheters have been safely and successfully used to cross challenging lesions in both arterial …See details»
FDA Clears XableCath Catheter for Peripheral Arterial Disease
Dec 17, 2017 The XableCath blunt-tip catheter is unique in its ability to cross chronic total occlusions quickly while remaining over-the-wire and in the true lumen. XableCath catheters …See details»
XableCath Reimagines Peripheral Vascular Care
XableCath has developed a low cost, manual metal-tipped over-the-wire catheter designed to remain in the true lumen of the artery. The start-up positions it as the treatment of first resort …See details»
XableCath gets US FDA clearance for broadly effective catheter …
Dec 19, 2017 XableCath has announced its XableCath blunt tip support catheter has received clearance from the US FDA. The blunt tip catheter facilitates true lumen passage of lesions, …See details»